CompletedNCT00994786
A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory OCD
Medication studyAges 18–65Canada
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- HamiltonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJanuary 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 15
- Sponsor
- McMaster University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00994786
- Official title
Show the full official title
A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder
Get this study by email
Recruitment & locations
CompletedHamilton
Questions about this study
Who is behind this study?
The study sponsor is McMaster University, a university.
Did this study involve medication?
Yes. The study involved medication, including pregabalin and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
